Brevan Howard Capital Management’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$393K	Sell	148,711 -197,233	-57%	-$521K	﹤0.01%	1365
2025 Q1	$1.04M	Buy	345,944 +246,187	+247%	+$741K	0.01%	442
2024 Q4	$255K	Buy	+99,757	New	+$255K	﹤0.01%	803
2024 Q3	–	Sell	-96,765	Closed	-$612K	–	1229
2024 Q2	$612K	Buy	+96,765	New	+$612K	0.01%	489